# Fifth Eye

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fifth-eye

- Industry: Healthcare IT
- Headquarters: Ann Arbor, US
- Website: www.fiftheye.com
- Total disclosed funding: $14M
- Latest round: Series A (Mar 19, 2019)
- Investors on record: 5

## About

Fifth Eye Inc. is a healthcare technology firm specializing in advanced patient monitoring solutions. The company utilizes AI to enhance clinical decision-making, specifically for predicting hemodynamic instability in patients.Fifth Eye Inc. was founded in 2017 and is headquartered in Ann Arbor, US. The company focuses on developing innovative healthcare technologies and has executed 2 deals, with its most recent being a Series A funding round in March 2019. The company was co-founded by Ashwin Belle, Bryce Benson, Jeffrey Basch, Jen Baird, and Mark Salamango, with Jen Baird currently serving as CEO. The Series A funding round raised USD 11.5 mn and was led by Arboretum Ventures and Cultivation Capital, along with participation from Michigan Investment in New Technology Startups and returning investor InvestMichigan! Growth Capital Fund.Fifth Eye Inc. offers the AirStrip Analytic for Hemodynamic Instability (AHI), an FDA-cleared, AI-powered patient monitoring solution. This technology detects patient compensation mechanisms and predicts hemodynamic instability using non-invasive, continuous ECG signals. The AHI collects physiological data, analyzes hemodynamic status, and updates every two minutes, featuring a multi-patient dashboard that aids healthcare providers in prioritizing patient care. The solution is primarily targeted at healthcare institutions, such as hospitals and critical care facilities in North America and Europe, and is utilized by clinicians and healthcare providers to monitor patients at risk of deterioration.Fifth Eye Inc. generates revenue through subscriptions and partnerships with healthcare institutions implementing the AHI monitoring solution. Clients enter contractual agreements for recurring payments that cover access to the technology, ongoing support, and updates. The pricing model may include tiered plans based on monitored patients, catering to the diverse needs of hospitals and healthcare facilities, with the flagship product, AirStrip AHI, being central to these transactions.In March 2019, Fifth Eye Inc. raised USD 11.5 mn in Series A funding to support future growth initiatives. The company plans to develop new products that enhance monitoring capabilities and aims to expand its market presence into Europe and Asia by 2023. The recent funding will help facilitate the launch of these innovations and support strategic partnerships with healthcare providers to ensure seamless integration of its solutions into existing systems.

## Funding rounds

- Series A, Mar 19, 2019, $12M — Arboretum Ventures, InvestMichigan! Growth Capital Fund, Cultivation Capital, Michigan Investment in New Technology Startups
- Seed, Jul 22, 2018, $2.4M — InvestMichigan! Growth Capital Fund, Biosciences Research & Commercialization Center

## Investors

- InvestMichigan! Growth Capital Fund — Seed, Series A
- Biosciences Research & Commercialization Center (https://capitalatlas.ai/funds/biosciences-research-commercialization-center) — Seed
- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series A
- Cultivation Capital (https://capitalatlas.ai/funds/cultivation-capital) — Series A
- Michigan Investment in New Technology Startups (https://capitalatlas.ai/funds/michigan-investment-in-new-technology-startups) — Series A